Therefore, we reintroduced HK2 levels in butyrate-treated CRC cells and found that ectopic expression of HK2 partially reversed the suppressive effects of butyrate on cell proliferation in LoVo cells (Fig. 6G, H) and HCT116 cells (Supplementary Fig. 6G–H). Here, HK2 is linked to colorectal carcinoma.